Bioventus Acquires BioStructures, Expands Surgical Orthobiologics Offering (press release)
Read all Bioventus articles
Bioventus, a global leader in orthobiologic solutions, today announced it has acquired BioStructures LLC, a proprietary developer and marketer of bioresorbable bone graft products for a broad range of spinal and orthopaedic surgical applications. The agreement includes the entire portfolio of products as well as its research and development pipeline. In addition, employees of BioStructures will be given offers to join Bioventus. Terms of the acquisition were not disclosed.
“This acquisition will continue to allow the culture of innovation, as well as advance the positive momentum we have built at BioStructures. We are happy to announce the transaction and look forward to the future with confidence and excitement.”
Tweet this
The BioStructures product portfolio includes synthetic, allograft, collagen, and demineralized bone matrix (DBM) solutions for surgeons. Its signature products are:Interface™ Bioactive Bonegraft, a synthetic graft used to repair osseous defects, andSignafuse™ Bioactive Bonegraft Putty comprised of a bi-phasic mineral composite combined with t...
